scholarly journals Effect of Gait Parameters On Balance and Quality of Life in Recovering Stroke Patients- A Correlation Study

2021 ◽  
Vol 6 (2) ◽  

Introduction: Stroke is neurovascular disease caused by disruption of blood flow to brain, result in neurological deficit. As a consequence of stroke there will be loss of leg strength and impaired balance that may affect walking ability. Gait parameters are also affected as a consequences of stroke. Overall affection of gait parameters and balance will affect Quality of Life. Objective: The study is conducted to find out relationship between Gait parameters, Balance and Quality of Life in recovering stroke patients- A Correlation Study” Material and Methodology: Total 32 patients were screened as per inclusion and exclusion criteria. Demographic data was taken. At the time of discharge from the hospital Health status was assessed with use of stroke Impact scale. TUG was taken to measure the Balance. Gait velocity was calculated by use of 6 minute walk test. Result: Total 32 Recovering stroke Patients have participated in the study. All the stroke patients who have participated in the study were having mean age of 52.65 years and participants of both the genders were included. Amongst the participants’ males were 78.21% and females were 21.9%. Were included in the study. Participants with both sided strokes were consider for data collection. Stroke impact scale score has found to have positive correlation with Gait velocity, and stride length, and negative correlation with TUG. (P = .001 to P = .031). TUG score correlated negatively with Gait Velocity and Stride Length. Conclusion: Gait parameters have impact on Quality of Life have but will not produce much difference on balance. There is no significant influence of gait parameters on Balance.

Stroke ◽  
2001 ◽  
Vol 32 (suppl_1) ◽  
pp. 361-361
Author(s):  
Sue-Min Lai Dr ◽  
Stephanie Studenski Dr ◽  
Pamela W Duncan Dr ◽  
Subashan Perera Dr

P123 Purpose: The purpose of this study was to determine the discriminant validity of the Stroke Impact Scale (SIS) by comparing function and quality of life in stroke patients to assessments from stroke-free community dwelling elderly. Methods: The SIS was administered at 90 to 120 days post-stroke to subjects who participated in the Kansas City Stroke Registry (KCSR). The same impact scale was also administered cross-sectionally to community dwelling elderly who were recruited from primary care clinics for participation in an ongoing prospective study of health and function (Merck). All subjects were queried for responses to 64 items of the SIS including eight domains: strength, memory and thinking, emotion, communication, ADL/IADL, mobility, upper extremity, and social participation. Regression analyses were used to examine differences between stroke patients and stroke-free elderly in each of the eight SIS domains while controlling for demographics and comorbidities. Results: One hundred and sixty KCSR subjects and two hundred and forty-three subjects from the Merck study were included in the present analysis. The mean ages were 73±10.1 and 74±5.1, respectively. Gender and race were similar in both groups. The 90-days post-stroke mean Barthel ADL was 80±23 in the stroke patients. Mean scores of all 8 SIS domains were significantly lower in stroke patients than those in the stroke-free community dwelling elderly even after controlling for differences in age and comorbidities (all p values < 0.0001). Mean scores of the 7 SIS domains (except strength), even in stroke patients who had Barthel ADL > 90 at 90-days post-stroke, remained lower than those in the stroke-free community dwelling elderly (p values < 0.01). Conclusion: The SIS was able to discriminate well between stroke patients with disability and stroke-free elderly subjects. Patients who had recovered basic ADLs continued to have residual disability and impaired quality of life when compared to non-stroke patients.


2018 ◽  
Vol 136 (2) ◽  
pp. 144-149
Author(s):  
Aline Dias Brandão ◽  
Natasha Bertocco Teixeira ◽  
Maria Claudia Brandão ◽  
Milena Carlos Vidotto ◽  
José Roberto Jardim ◽  
...  

Author(s):  
◽  
◽  

HIV can cause numerous health-related complications that can lead to disabilities and affect the quality of life. Some problems added with HIV, like peripheral neuropathy (PN), may develop additional impediments in this population. Purpose: This study investigated PN’s impact on the cardio-motor profile of Hispanic Latino living with HIV. Methods: A submaximal cardiovascular test (Ross test) was conducted to obtain the study’s cardiomotor results. Cardiomotor data were compiled from records of members enrolled at La Perla de Gran Precio Community Centre on HIV in San Juan, Puerto Rico. Results: The motor profile included the speed and inclination of the treadmill. The cardiovascular data had blood pressure and heart rate at the time Ross’s test was terminated. Two hundred and ninety-one participants were further designated as 225 in the non-PN and 66 in the PN group. Both groups average comparable amounts of CD4 counts. An ANOVA was used to determine variations in the PN group with a considerable (P < 0.05) increase in the time of HIV diagnosis and a reduction in gait velocity and treadmill inclination distinguished to counterpart. Conclusion: Hispanic Latino living with HIV and PN displayed distinctive motor gait deficiencies. Gait parameters, such as gait speed, were further impaired in those suffering from both conditions. We encourage healthcare providers to incorporate the specific cardio-motor items alluded to in this investigation to identify the process influencing gait that further alters the quality of life in those with HIV.


2015 ◽  
Vol 38 (14) ◽  
pp. 1425-1430 ◽  
Author(s):  
Marina Richardson ◽  
Nerissa Campbell ◽  
Laura Allen ◽  
Matthew Meyer ◽  
Robert Teasell

2020 ◽  
Author(s):  
Christopher Miles ◽  
Andrew Greene

Abstract Background Osteoarthritis is a major cause of pain and disability worldwide, therefore ways of treating this condition are paramount to a successful health system. The purpose of the study was to investigate the changes in spatial-temporal gait parameters and clinical measurements following treatment with a non-invasive biomechanical device on patients with knee osteoarthritis within the UK. Methods A retrospective analysis was carried out on 455 patients with knee osteoarthritis. All patients were evaluated using a computerized gait test and two self-assessment questionnaires (WOMAC and SF-36) at baseline and after 3 and 6 months of treatment. The biomechanical device was individually calibrated for each patient to minimise symptoms whilst walking and train neuromuscular control. Patients used the device for short periods during activities of daily living. Repeated measures statistical analyses were performed to compare differences over time. Results After 6 months of therapy significant improvements were seen in all gait parameters (p<0.01). Specifically, gait velocity, step length and single limb support of the more symptomatic knee improved by 13%, 7.8% and 3%, respectively. These were supported by significant improvements in pain, function and quality of life (48.6%, 45.7% and 22% respectively; p<0.001). A sub-group analysis revealed no baseline differences between those who were recommended joint replacement and those who were not. Both groups improved significantly over time (p<0.05 for all). Conclusions Our results suggest the personalised biomechanical intervention can improve gait patterns, pain, function and quality of life. It may provide an additional solution to managing UK patients suffering from knee osteoarthritis.


2020 ◽  
Author(s):  
Augustine J Devasahayam ◽  
Arthur R Chaves ◽  
Wendy O Lasisi ◽  
Marie E Curtis ◽  
Katie P Wadden ◽  
...  

Abstract Background: Aerobic training has the potential to restore function, stimulate brain repair, and reduce inflammation in people with Multiple Sclerosis (MS). However, disability, fatigue, and heat sensitivity are major barriers to exercise for people with MS. We aimed to determine the feasibility of conducting vigorous harness-supported treadmill training in a room cooled to 16°C (10 weeks; 3times/week) and examine the longer-term effects on markers of function, brain repair, and inflammation among those using ambulatory aids. Methods: Ten participants (9 females) aged 29 to 74 years with an Expanded Disability Status Scale ranging from 6 to 7 underwent training (40 to 65% heart rate reserve) starting at 80% self-selected walking speed. Feasibility of conducting vigorous training was assessed using a checklist, which included attendance rates, number of missed appointments, reasons for not attending, adverse events, safety hazards during training, reasons for dropout, tolerance to training load, subjective reporting of symptom worsening during and after exercise, and physiological responses to exercise. Functional outcomes were assessed before, after, and 3 months after training. Walking ability was measured using Timed 25 Foot Walk test and on an instrumented walkway at both fast and self-selected speeds. Fatigue was measured using fatigue/energy/vitality sub-scale of 36-Item Short-Form (SF-36) Health Survey, Fatigue Severity Scale, modified Fatigue Impact Scale. Aerobic fitness (maximal oxygen consumption) was measured using maximal graded exercise test (GXT). Quality-of-life was measured using SF-36 Health Survey. Serum levels of neurotrophin (brain-derived neurotrophic factor) and cytokine (interleukin-6) were assessed before and after GXT. Results: Eight of the ten participants completed training (attendance rates >80%). No adverse events were observed. Fast walking speed (cm/s), gait quality (double-support (%)) while walking at self-selected speed, fatigue (modified Fatigue Impact Scale), fitness (maximal workload achieved during GXT), and quality-of-life (physical functioning sub-scale of SF-36) improved significantly after training, and improvements were sustained after 3-months. Improvements in fitness (maximal respiratory exchange ratio and maximal oxygen consumption during GXT) were associated with increased brain-derived neurotrophic factor and decreased interleukin-6. Conclusion: Vigorous cool room training is feasible and can potentially improve walking, fatigue, fitness, and quality-of-life among people with moderate to severe MS-related disability.


Author(s):  
Natalie E. Parks ◽  
Gail A. Eskes ◽  
Gordon J. Gubitz ◽  
Yvette Reidy ◽  
Christine Christian ◽  
...  

Background:Fatigue affects 33-77% of stroke survivors. There is no consensus concerning risk factors for fatigue post-stroke, perhaps reflecting the multifaceted nature of fatigue. We characterized post-stroke fatigue using the Fatigue Impact Scale (FIS), a validated questionnaire capturing physical, cognitive, and psychosocial aspects of fatigue.Methods:The Stroke Outcomes Study (SOS) prospectively enrolled ischemic stroke patients from 2001-2002. Measures collected included basic demographics, pre-morbid function (Oxford Handicap Scale, OHS), stroke severity (Stroke Severity Scale, SSS), stroke subtype (Oxfordshire Community Stroke Project Classification, OCSP), and discharge function (OHS; Barthel Index, BI). An interview was performed at 12 months evaluating function (BI; Modified Rankin Score, mRS), quality of life (Reintegration into Normal living Scale, RNL), depression (Geriatric Depression Scale, GDS), and fatigue (FIS).Results:We enrolled 522 ischemic stroke patients and 228 (57.6%) survivors completed one-year follow-up. In total, 36.8% endorsed fatigue (59.5% rated one of worst post-stroke symptoms). Linear regression demonstrated younger age was associated with increased fatigue frequency (β=-0.20;p=0.01), duration (β=-0.22;p<0.01), and disability (β=-0.24;p<0.01). Younger patients were more likely to describe fatigue as one of the worst symptoms post-stroke (β=-0.24;p=0.001). Younger patients experienced greater impact on cognitive (β=-0.27;p<0.05) and psychosocial (β=-0.27;p<0.05) function due to fatigue. Fatigue was correlated with depressive symptoms and diminished quality of life. Fatigue occurred without depression as 49.0% of respondents with fatigue as one of their worst symptoms did not have an elevated GDS.Conclusions:Age was the only consistent predictor of fatigue severity at one year. Younger participants experienced increased cognitive and psychosocial fatigue.


Sign in / Sign up

Export Citation Format

Share Document